DJIA 18,285.74 0.34 0.00%
NASDAQ 5,090.79 19.05 0.38%
S&P 500 2,130.82 4.97 0.23%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

43.76 0.77 (1.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $43.76 1.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.14
Previous Close $42.99
Daily Range $42.50 - $43.89
52-Week Range $30.05 - $44.95
Market Cap $5.5B
P/E Ratio -65.14
Dividend (Yield) $0.00 (0.0%)
Volume 1,698,425
Average Daily Volume 1,183,841
Current FY EPS -$0.76

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) Is Today's Perilous Reversal Stock

Insider Trading Alert - SGEN, NSP And TSCO Traded By Insiders

Insider Weekends - May 8, 2015

Seattle Genetics director buys more than 1 million shares

Credit Suisse Analysts Assume Coverage On 10 Biotech Stocks

See More SGEN News...

SGEN's Top Competitors

SGEN $43.76 (1.79%)
Current stock: SGEN
AMGN $163.84 (-0.09%)
Current stock: AMGN
GILD $111.22 (0.95%)
Current stock: GILD
BIIB $401.15 (0.04%)
Current stock: BIIB